查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
母乳低聚醣 (HMO) 市场、份额、规模、趋势、行业分析报告：按类型；按应用；按分销管道；按地区；细分市场预测，2023-2032 年
市场调查报告书
商品编码
1346940

母乳低聚醣 (HMO) 市场、份额、规模、趋势、行业分析报告：按类型；按应用；按分销管道；按地区；细分市场预测，2023-2032 年

Human Milk Oligosaccharides (HMO) Market Share, Size, Trends, Industry Analysis Report, By Type (2'FL, 3'FL, 3'SL, 6'SL); By Application; By Distribution Channel; By Region; Segment Forecast, 2023 - 2032
出版日期: | 出版商: Polaris Market Research | 英文 118 Pages | 商品交期: 最快1-2个工作天内

价格

根据 Polaris Market Research 的一项新研究，到 2032 年，全球母乳寡糖 (HMO) 市场规模预计将达到 17.9996 亿美元。 该报告提供了对当前市场动态的详细洞察，并对未来市场成长进行了分析。

母乳寡糖 (HMO) 是母乳中天然存在的复杂碳水化合物或糖。 HMO 是人类母乳所特有的，在其他哺乳动物（包括牛奶）的乳汁中含量并不高。

HMO 作为婴儿的营养来源，但它们不会被婴儿直接消化。 相反，HMO 充当益生元，餵养婴儿肠道中的有益细菌。 您的肠道微生物组对于免疫系统发育、消化和整体健康极为重要。 HMO 选择性地促进某些有益细菌（例如双歧桿菌）的生长，同时抑制有害病原体的生长。

母乳寡糖 (HMO) 是母乳的重要成分，有各种浓度和成分。 HMO 的独特性质需要特定的监管部门批准其使用。 在美国，低聚醣被批准添加到食品中，而不是被归类为膳食补充剂，并受到公认安全 (GRAS) 法规的约束。

例如，经 GRAS 批准的 HMO 产品线是 CARE4U，由Du Pont开发，用于婴儿配方奶粉和婴儿食品。 此批准确保了消费安全。 此外，对 HMO 的需求不断增长，催生了新的食品安全评估，并寻求欧盟委员会对其使用的支持。

全球对母乳寡糖 (HMO) 的采用正在增加。 根据世界经济论坛2022年1月发表的文章，日本2020年的出生人数比前一年下降2.8%，为1899年以来的最低水准。

对 HMO 需求的增加是由于生活方式的改善以及对健康和保健的兴趣增加。 HMO 用于功能性食品和饮料以及食品补充剂中，以解决疾病并缓解高风险健康状况。 这一因素对全球 HMO 产业的成长做出了重大贡献。 然而，与 HMO 产品相关的高成本预计将成为预测期内市场成长的主要挑战。

COVID-19 大流行对 HMO 产业产生了重大影响。 疫情爆发之初，由于消费者恐慌性购买居家消费，对 HMO 的需求激增。 因此，被认为是增强免疫力的产品的 HMO 的销售量增加。

母乳低聚醣 (HMO) 市场报告亮点

2022年，由于婴儿配方奶粉设计中对HMO的需求不断增加，婴儿配方奶粉产业占据了最大的市场份额。 HMO 具有益生元作用、预防感染、增强记忆、维持肠道健康和大脑发育等有益特性。 这些因素推动了婴儿配方奶粉中 HMO 的需求。

到 2022 年，药局或药局细分市场在母乳低聚醣市场中占据最高市场份额，并且预计将继续成长。 这主要是由于在邮购零售商和超级中心的竞争日益激烈的情况下，该部门专注于客户获取和保留。

在亚太地区，由于人们越来越认识到母乳寡糖 (HMO) 在婴儿营养和整体健康方面的益处，母乳低聚醣 (HMO) 市场预计将大幅成长。 随着消费者健康意识的增强并为婴儿寻求高品质的营养选择，对 HMO 的需求预计将会增加。

Elicityl S.A.、Abbott Laboratories、Biosynth Carbosynth、Dextra Laboratories Ltd.、Dupont Nutrition &Biosciences、Glycosyn、BASF S.E.、Glycom A/S、Nestle Health Science、Neolacta Lifesciences Pvt.Ltd.、Royal DSM、Medolac Laboratories、遍布全球的全球母乳低聚醣产业参与者，包括Chr. Hansen Holding A/S、ZuChem、Inbiose NV、Royal FrieslandCampina N.V.

目录

第一章简介

第 2 章执行摘要

第三章研究方法

第四章全球母乳寡糖 (HMO) 市场洞察

  • 母乳寡糖 (HMO) - 产业快照
  • 母乳寡糖 (HMO) 市场动态
    • 推动者和机会
      • 婴儿人口增加
      • 提高人们对母乳哺育重要性的认识
    • 抑制因素和挑战
      • 数量有限
  • PESTEL 分析
  • 母乳寡糖 (HMO) 市场的产业趋势
  • 价值链分析
  • COVID-19 感染的影响分析

第五章按类型划分的全球母乳低聚醣 (HMO) 市场

  • 主要发现
  • 简介
  • 2 佛罗里达州
  • 3 佛罗里达州
  • 3'SL
  • 6SL

第 6 章全球母乳寡糖 (HMO) 市场（依应用）

  • 主要发现
  • 简介
  • 婴儿配方奶粉
  • 功能性食品和饮料
  • 营养补充品

第 7 章全球母乳寡糖 (HMO) 市场（依通路）

  • 主要发现
  • 简介
  • 大卖场与超市
  • 药局或药房
  • 线上销售管道
  • 其他

第 8 章全球母乳寡糖 (HMO) 市场、地区

  • 主要发现
  • 简介
    • 2019-2032 年母乳寡糖 (HMO) 市场评估，地区
  • 母乳寡糖 (HMO) 市场 - 北美
    • 北美：母乳寡糖 (HMO) 市场（按类型），2019-2032 年
    • 北美：母乳寡糖 (HMO) 市场（依通路），2019-2032 年
    • 北美：母乳寡糖 (HMO) 市场，按应用划分，2019-2032 年
    • 母乳寡糖 (HMO) 市场 – 美国
    • 母乳寡糖 (HMO) 市场 - 加拿大
  • 母乳寡糖 (HMO) 市场 - 欧洲
    • 欧洲：母乳寡糖 (HMO) 市场（按类型），2019-2032 年
    • 欧洲：母乳寡糖 (HMO) 市场（依通路），2019-2032 年
    • 欧洲：母乳寡糖 (HMO) 市场，按应用划分，2019-2032 年
    • 母乳寡糖 (HMO) 市场 - 英国
    • 母乳寡糖 (HMO) 市场 - 法国
    • 母乳寡糖 (HMO) 市场 - 德国
    • 母乳寡糖 (HMO) 市场 - 义大利
    • 母乳寡糖 (HMO) 市场 - 西班牙
    • 母乳寡糖 (HMO) 市场 - 荷兰
    • 母乳寡糖 (HMO) 市场 - 俄罗斯
  • 母乳寡糖 (HMO) 市场 - 亚太地区
    • 亚太地区：母乳寡糖 (HMO) 市场（按类型），2019-2032 年
    • 亚太地区：母乳寡糖 (HMO) 市场（依通路），2019-2032 年
    • 亚太地区：母乳寡糖 (HMO) 市场，依应用划分，2019-2032 年
    • 母乳寡糖 (HMO) 市场 - 中国
    • 母乳寡糖 (HMO) 市场 - 印度
    • 母乳寡糖 (HMO) 市场 - 马来西亚
    • 母乳寡糖 (HMO) 市场 - 日本
    • 母乳寡糖 (HMO) 市场 - 印尼
    • 母乳寡糖 (HMO) 市场 - 韩国
  • 母乳寡糖 (HMO) 市场 - 中东和非洲
    • 中东和非洲：母乳寡糖 (HMO) 市场（按类型），2019-2032 年
    • 中东和非洲：母乳低聚醣 (HMO) 市场（按分销管道），2019-2032 年
    • 中东和非洲：母乳寡糖 (HMO) 市场，按应用划分，2019-2032 年
    • 母乳寡糖 (HMO) 市场 - 沙乌地阿拉伯
    • 母乳寡糖 (HMO) 市场 - 阿拉伯联合大公国
    • 母乳寡糖 (HMO) 市场 - 以色列
    • 母乳寡糖 (HMO) 市场 - 南非
  • 母乳寡糖 (HMO) 市场 - 拉丁美洲
    • 拉丁美洲：母乳寡糖 (HMO) 市场（按类型），2019-2032 年
    • 拉丁美洲：母乳寡糖 (HMO) 市场，依通路划分，2019-2032 年
    • 拉丁美洲：母乳寡糖 (HMO) 市场，按应用划分，2019-2032 年
    • 母乳寡糖 (HMO) 市场 - 墨西哥
    • 母乳寡糖 (HMO) 市场 - 巴西
    • 母乳寡糖 (HMO) 市场 - 阿根廷

第九章竞争态势

  • 扩张与收购分析
    • 放大
    • 收购
  • 伙伴关係/协作/协议/揭露

第十章公司简介

  • Abbott Laboratories
  • BASF S.E
  • Biosynth Carbosynth
  • Chr. Hansen Holding A/S
  • Dextra Laboratories Ltd
  • Dupont Nutrition & Biosciences
  • Elicityl S.A.
  • Glycom A/S
  • Glycosyn
  • Inbiose NV
  • Medolac Laboratories
  • Neolacta Lifesciences Pvt. Ltd
  • Nestle Health Science
  • Royal DSM
  • Royal FrieslandCampina N.V
  • ZuChem
Product Code: PM2516

The global human milk oligosaccharides (HMO) market size is expected to reach USD 1,799.96 million by 2032, according to a new study by Polaris Market Research. The report "Human Milk Oligosaccharides (HMO) Market Share, Size, Trends, Industry Analysis Report, By Type (2'FL, 3'FL, 3'SL, 6'SL); By Application; By Distribution Channel; By Region; Segment Forecast, 2023 - 2032" gives a detailed insight into current market dynamics and provides analysis on future market growth.

Human Milk Oligosaccharides (HMOs) are complex carbohydrates or sugars naturally found in human breast milk. HMOs are unique to human milk and are not present in significant amounts in other mammalian milk, including cow's milk.

HMOs serve as a source of infant nutrition, although the baby does not directly digest them. Instead, they act as prebiotics, which means they serve as food for beneficial bacteria in the infant's gut. The gut microbiota is crucial in immune system development, digestion, and overall health. HMOs selectively promote the growth of specific beneficial bacteria, such as Bifidobacteria, while inhibiting the growth of harmful pathogens.

Human Milk Oligosaccharides (HMOs) are essential constituents of human breast milk and are available in various concentrations and compositions. The unique nature of HMOs requires specific regulatory approvals for their use. In the United States, oligosaccharides are authorized to be incorporated into food products rather than categorized as dietary supplements and are subject to the Generally Recognized as Safe (GRAS) regulations.

For instance, the GRAS-approved HMO product line is CARE4U, developed by DuPont, which is utilized in infant formula and toddler foods. This approval ensures its safety for consumption. Furthermore, the growing demand for HMOs has led to a novel food safety assessment to seek support from the European Commission for their usage.

The global adoption of Human Milk Oligosaccharides (HMOs) has increased. According to a World Economic Forum article published in January 2022, the number of births in Japan decreased by 2.8% in 2020 compared to the previous year, reaching its lowest point since 1899.

The increasing demand for HMOs can be attributed to lifestyle improvements and a growing focus on health and wellness. HMOs are utilized in functional food and beverage products and food supplements to address disorders and mitigate high-risk health conditions. This factor has significantly contributed to the growth of the global HMO industry. However, the high costs associated with HMO products are expected to pose a major challenge to market growth during the forecast period.

The COVID-19 pandemic has had a significant impact on the HMO industry. During the initial phase of the pandemic, there was a surge in demand for HMOs as consumers engaged in panic buying for at-home consumption. It resulted in increased sales of HMOs, considered immune-boosting products.

Human Milk Oligosaccharides (HMO) Market Report Highlights

In 2022, the infant formula segment accounted for the largest market share due to the increasing demand for HMOs in infant formula design. HMOs offer beneficial properties like prebiotic effects, infection prevention, memory enhancement, gut health maintenance, and brain development. These factors drive the demand for HMOs in infant formulas.

In 2022, the drug store or pharmacy segment held the highest market share in the Human Milk Oligosaccharides market and is projected to continue growing. It is primarily due to the segment's focus on attracting and retaining customers amidst rising competition from mail-order retailers and supercenters.

The Asia Pacific region expected to witness significant growth in the Human Milk Oligosaccharides (HMO) market due to growing awareness of the benefits of HMOs in infant nutrition and overall health in the region. As consumers become more health-conscious and seek high-quality nutrition options for their infants, the demand for HMOs is expected to rise.

The global Human Milk Oligosaccharides industry players with a global presence including Elicityl S.A., Abbott Laboratories, Biosynth Carbosynth, Dextra Laboratories Ltd., Dupont Nutrition & Biosciences, Glycosyn, BASF S.E., Glycom A/S, Nestle Health Science, Neolacta Lifesciences Pvt. Ltd, Royal DSM, Medolac Laboratories, Chr. Hansen Holding A/S, ZuChem, Inbiose NV, and Royal FrieslandCampina N.V.

Polaris Market Research has segmented the human milk oligosaccharides (HMO) market report based on type, application, distribution channel, and region:

Human Milk Oligosaccharides (HMO), Type Outlook (Revenue - USD Million, 2019 - 2032)

  • 2'FL
  • 3'FL
  • 3'SL
  • 6'SL

Human Milk Oligosaccharides (HMO), Application Outlook (Revenue - USD Million, 2019 - 2032)

  • Infant Formula
  • Functional Food & Beverage
  • Food Supplements

Human Milk Oligosaccharides (HMO), Distribution Channel Outlook (Revenue - USD Million, 2019 - 2032)

  • Hypermarkets & Supermarkets
  • Drug Store or Pharmacy
  • Online Sales Channel
  • Others

Fogless Mirror, Regional Outlook (Revenue - USD Million, 2019 - 2032)

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Spain
    • Russia
    • Netherlands
  • Asia Pacific
    • China
    • India
    • Japan
    • South Korea
    • Indonesia
    • Malaysia
  • Latin America
    • Argentina
    • Brazil
    • Mexico
  • Middle East & Africa
    • UAE
    • Saudi Arabia
    • Israel
    • South Africa

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Sources
    • 3.2.1. Primary Sources
    • 3.2.2. Secondary Sources

4. Global Human Milk Oligosaccharides (HMO) Market Insights

  • 4.1. Human Milk Oligosaccharides (HMO) - Industry Snapshot
  • 4.2. Human Milk Oligosaccharides (HMO) Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Increase in the infant population
      • 4.2.1.2. Growing awareness of the importance of breastfeeding
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. Limited availability
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTEL Analysis
  • 4.5. Human Milk Oligosaccharides (HMO) Market Industry Trends
  • 4.6. Value Chain Analysis
  • 4.7. COVID-19 Impact Analysis

5. Global Human Milk Oligosaccharides (HMO) Market, by Type

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global Human Milk Oligosaccharides (HMO) Market, by Type, 2019 - 2032 (USD Million)
  • 5.3. 2'FL
    • 5.3.1. Global Human Milk Oligosaccharides (HMO) Market, by 2'FL, by Region, 2019 - 2032 (USD Million)
  • 5.4. 3'FL
    • 5.4.1. Global Human Milk Oligosaccharides (HMO) Market, by 3'FL, by Region, 2019 - 2032 (USD Million)
  • 5.5. 3'SL
    • 5.5.1. Global Human Milk Oligosaccharides (HMO) Market, by 3'SL, by Region, 2019 - 2032 (USD Million)
  • 5.6. 6'SL
    • 5.6.1. Global Human Milk Oligosaccharides (HMO) Market, by 6'SL, by Region, 2019 - 2032 (USD Million)

6. Global Human Milk Oligosaccharides (HMO) Market, by Application

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global Human Milk Oligosaccharides (HMO) Market, by Application, 2019 - 2032 (USD Million)
  • 6.3. Infant Formula
    • 6.3.1. Global Human Milk Oligosaccharides (HMO) Market, by Infant Formula, by Region, 2019 - 2032 (USD Million)
  • 6.4. Functional Food & Beverage
    • 6.4.1. Global Human Milk Oligosaccharides (HMO) Market, by Functional Food & Beverage, by Region, 2019 - 2032 (USD Million)
  • 6.5. Food Supplements
    • 6.5.1. Global Human Milk Oligosaccharides (HMO) Market, by Food Supplements, by Region, 2019 - 2032 (USD Million)

7. Global Human Milk Oligosaccharides (HMO) Market, by Distribution channel

  • 7.1. Key Findings
  • 7.2. Introduction
    • 7.2.1. Global Human Milk Oligosaccharides (HMO) Market, by Distribution channel, 2019 - 2032 (USD Million)
  • 7.3. Hypermarkets & Supermarkets
    • 7.3.1. Global Human Milk Oligosaccharides (HMO) Market, by Hypermarkets & Supermarkets, by Region, 2019 - 2032 (USD Million)
  • 7.4. Drug Store or Pharmacy
    • 7.4.1. Global Human Milk Oligosaccharides (HMO) Market, by Drug Store or Pharmacy, by Region, 2019 - 2032 (USD Million)
  • 7.5. Online Sales Channel
    • 7.5.1. Global Human Milk Oligosaccharides (HMO) Market, by Online Sales Channel, by Region, 2019 - 2032 (USD Million)
  • 7.6. Others
    • 7.6.1. Global Human Milk Oligosaccharides (HMO) Market, by Others, by Region, 2019 - 2032 (USD Million)

8. Global Human Milk Oligosaccharides (HMO) Market, by Geography

  • 8.1. Key findings
  • 8.2. Introduction
    • 8.2.1. Human Milk Oligosaccharides (HMO) Market Assessment, By Geography, 2019 - 2032 (USD Million)
  • 8.3. Human Milk Oligosaccharides (HMO) Market - North America
    • 8.3.1. North America: Human Milk Oligosaccharides (HMO) Market, by Type, 2019 - 2032 (USD Million)
    • 8.3.2. North America: Human Milk Oligosaccharides (HMO) Market, by Distribution channel, 2019 - 2032 (USD Million)
    • 8.3.3. North America: Human Milk Oligosaccharides (HMO) Market, by Application, 2019 - 2032 (USD Million)
    • 8.3.4. Human Milk Oligosaccharides (HMO) Market - U.S.
      • 8.3.4.1. U.S.: Human Milk Oligosaccharides (HMO) Market, by Type, 2019 - 2032 (USD Million)
      • 8.3.4.2. U.S.: Human Milk Oligosaccharides (HMO) Market, by Distribution channel, 2019 - 2032 (USD Million)
      • 8.3.4.3. U.S.: Human Milk Oligosaccharides (HMO) Market, by Application, 2019 - 2032 (USD Million)
    • 8.3.5. Human Milk Oligosaccharides (HMO) Market - Canada
      • 8.3.5.1. Canada: Human Milk Oligosaccharides (HMO) Market, by Type, 2019 - 2032 (USD Million)
      • 8.3.5.2. Canada.: Human Milk Oligosaccharides (HMO) Market, by Distribution channel, 2019 - 2032 (USD Million)
      • 8.3.5.3. Canada: Human Milk Oligosaccharides (HMO) Market, by Application, 2019 - 2032 (USD Million)
  • 8.4. Human Milk Oligosaccharides (HMO) Market - Europe
    • 8.4.1. Europe: Human Milk Oligosaccharides (HMO) Market, by Type, 2019 - 2032 (USD Million)
    • 8.4.2. Europe.: Human Milk Oligosaccharides (HMO) Market, by Distribution channel, 2019 - 2032 (USD Million)
    • 8.4.3. Europe: Human Milk Oligosaccharides (HMO) Market, by Application, 2019 - 2032 (USD Million)
    • 8.4.4. Human Milk Oligosaccharides (HMO) Market - UK
      • 8.4.4.1. UK: Human Milk Oligosaccharides (HMO) Market, by Type, 2019 - 2032 (USD Million)
      • 8.4.4.2. UK.: Human Milk Oligosaccharides (HMO) Market, by Distribution channel, 2019 - 2032 (USD Million)
      • 8.4.4.3. UK: Human Milk Oligosaccharides (HMO) Market, by Application, 2019 - 2032 (USD Million)
    • 8.4.5. Human Milk Oligosaccharides (HMO) Market - France
      • 8.4.5.1. France: Human Milk Oligosaccharides (HMO) Market, by Type, 2019 - 2032 (USD Million)
      • 8.4.5.2. France.: Human Milk Oligosaccharides (HMO) Market, by Distribution channel, 2019 - 2032 (USD Million)
      • 8.4.5.3. France: Human Milk Oligosaccharides (HMO) Market, by Application, 2019 - 2032 (USD Million)
    • 8.4.6. Human Milk Oligosaccharides (HMO) Market - Germany
      • 8.4.6.1. Germany: Human Milk Oligosaccharides (HMO) Market, by Type, 2019 - 2032 (USD Million)
      • 8.4.6.2. Germany.: Human Milk Oligosaccharides (HMO) Market, by Distribution channel, 2019 - 2032 (USD Million)
      • 8.4.6.3. Germany: Human Milk Oligosaccharides (HMO) Market, by Application, 2019 - 2032 (USD Million)
    • 8.4.7. Human Milk Oligosaccharides (HMO) Market - Italy
      • 8.4.7.1. Italy: Human Milk Oligosaccharides (HMO) Market, by Type, 2019 - 2032 (USD Million)
      • 8.4.7.2. Italy.: Human Milk Oligosaccharides (HMO) Market, by Distribution channel, 2019 - 2032 (USD Million)
      • 8.4.7.3. Italy: Human Milk Oligosaccharides (HMO) Market, by Application, 2019 - 2032 (USD Million)
    • 8.4.8. Human Milk Oligosaccharides (HMO) Market - Spain
      • 8.4.8.1. Spain: Human Milk Oligosaccharides (HMO) Market, by Type, 2019 - 2032 (USD Million)
      • 8.4.8.2. Spain.: Human Milk Oligosaccharides (HMO) Market, by Distribution channel, 2019 - 2032 (USD Million)
      • 8.4.8.3. Spain: Human Milk Oligosaccharides (HMO) Market, by Application, 2019 - 2032 (USD Million)
    • 8.4.9. Human Milk Oligosaccharides (HMO) Market - Netherlands
      • 8.4.9.1. Netherlands: Human Milk Oligosaccharides (HMO) Market, by Type, 2019 - 2032 (USD Million)
      • 8.4.9.2. Netherlands.: Human Milk Oligosaccharides (HMO) Market, by Distribution channel, 2019 - 2032 (USD Million)
      • 8.4.9.3. Netherlands: Human Milk Oligosaccharides (HMO) Market, by Application, 2019 - 2032 (USD Million)
    • 8.4.10. Human Milk Oligosaccharides (HMO) Market - Russia
      • 8.4.10.1. Russia: Human Milk Oligosaccharides (HMO) Market, by Type, 2019 - 2032 (USD Million)
      • 8.4.10.2. Russia.: Human Milk Oligosaccharides (HMO) Market, by Distribution channel, 2019 - 2032 (USD Million)
      • 8.4.10.3. Russia: Human Milk Oligosaccharides (HMO) Market, by Application, 2019 - 2032 (USD Million)
  • 8.5. Human Milk Oligosaccharides (HMO) Market - Asia Pacific
    • 8.5.1. Asia Pacific: Human Milk Oligosaccharides (HMO) Market, by Type, 2019 - 2032 (USD Million)
    • 8.5.2. Asia Pacific.: Human Milk Oligosaccharides (HMO) Market, by Distribution channel, 2019 - 2032 (USD Million)
    • 8.5.3. Asia Pacific: Human Milk Oligosaccharides (HMO) Market, by Application, 2019 - 2032 (USD Million)
    • 8.5.4. Human Milk Oligosaccharides (HMO) Market - China
      • 8.5.4.1. China: Human Milk Oligosaccharides (HMO) Market, by Type, 2019 - 2032 (USD Million)
      • 8.5.4.2. China.: Human Milk Oligosaccharides (HMO) Market, by Distribution channel, 2019 - 2032 (USD Million)
      • 8.5.4.3. China: Human Milk Oligosaccharides (HMO) Market, by Application, 2019 - 2032 (USD Million)
    • 8.5.5. Human Milk Oligosaccharides (HMO) Market - India
      • 8.5.5.1. India: Human Milk Oligosaccharides (HMO) Market, by Type, 2019 - 2032 (USD Million)
      • 8.5.5.2. India.: Human Milk Oligosaccharides (HMO) Market, by Distribution channel, 2019 - 2032 (USD Million)
      • 8.5.5.3. India: Human Milk Oligosaccharides (HMO) Market, by Application, 2019 - 2032 (USD Million)
    • 8.5.6. Human Milk Oligosaccharides (HMO) Market - Malaysia
      • 8.5.6.1. Malaysia: Human Milk Oligosaccharides (HMO) Market, by Type, 2019 - 2032 (USD Million)
      • 8.5.6.2. Malaysia.: Human Milk Oligosaccharides (HMO) Market, by Distribution channel, 2019 - 2032 (USD Million)
      • 8.5.6.3. Malaysia: Human Milk Oligosaccharides (HMO) Market, by Application, 2019 - 2032 (USD Million)
    • 8.5.7. Human Milk Oligosaccharides (HMO) Market - Japan
      • 8.5.7.1. Japan: Human Milk Oligosaccharides (HMO) Market, by Type, 2019 - 2032 (USD Million)
      • 8.5.7.2. Japan.: Human Milk Oligosaccharides (HMO) Market, by Distribution channel, 2019 - 2032 (USD Million)
      • 8.5.7.3. Japan: Human Milk Oligosaccharides (HMO) Market, by Application, 2019 - 2032 (USD Million)
    • 8.5.8. Human Milk Oligosaccharides (HMO) Market - Indonesia
      • 8.5.8.1. Indonesia: Human Milk Oligosaccharides (HMO) Market, by Type, 2019 - 2032 (USD Million)
      • 8.5.8.2. Indonesia.: Human Milk Oligosaccharides (HMO) Market, by Distribution channel, 2019 - 2032 (USD Million)
      • 8.5.8.3. Indonesia: Human Milk Oligosaccharides (HMO) Market, by Application, 2019 - 2032 (USD Million)
    • 8.5.9. Human Milk Oligosaccharides (HMO) Market - South Korea
      • 8.5.9.1. South Korea: Human Milk Oligosaccharides (HMO) Market, by Type, 2019 - 2032 (USD Million)
      • 8.5.9.2. South Korea.: Human Milk Oligosaccharides (HMO) Market, by Distribution channel, 2019 - 2032 (USD Million)
      • 8.5.9.3. South Korea: Human Milk Oligosaccharides (HMO) Market, by Application, 2019 - 2032 (USD Million)
  • 8.6. Human Milk Oligosaccharides (HMO) Market - Middle East & Africa
    • 8.6.1. Middle East & Africa: Human Milk Oligosaccharides (HMO) Market, by Type, 2019 - 2032 (USD Million)
    • 8.6.2. Middle East & Africa.: Human Milk Oligosaccharides (HMO) Market, by Distribution channel, 2019 - 2032 (USD Million)
    • 8.6.3. Middle East & Africa: Human Milk Oligosaccharides (HMO) Market, by Application, 2019 - 2032 (USD Million)
    • 8.6.4. Human Milk Oligosaccharides (HMO) Market - Saudi Arabia
      • 8.6.4.1. Saudi Arabia: Human Milk Oligosaccharides (HMO) Market, by Type, 2019 - 2032 (USD Million)
      • 8.6.4.2. Saudi Arabia.: Human Milk Oligosaccharides (HMO) Market, by Distribution channel, 2019 - 2032 (USD Million)
      • 8.6.4.3. Saudi Arabia: Human Milk Oligosaccharides (HMO) Market, by Application, 2019 - 2032 (USD Million)
    • 8.6.5. Human Milk Oligosaccharides (HMO) Market - UAE
      • 8.6.5.1. UAE: Human Milk Oligosaccharides (HMO) Market, by Type, 2019 - 2032 (USD Million)
      • 8.6.5.2. UAE.: Human Milk Oligosaccharides (HMO) Market, by Distribution channel, 2019 - 2032 (USD Million)
      • 8.6.5.3. UAE: Human Milk Oligosaccharides (HMO) Market, by Application, 2019 - 2032 (USD Million)
    • 8.6.6. Human Milk Oligosaccharides (HMO) Market - Israel
      • 8.6.6.1. Israel: Human Milk Oligosaccharides (HMO) Market, by Type, 2019 - 2032 (USD Million)
      • 8.6.6.2. Israel.: Human Milk Oligosaccharides (HMO) Market, by Distribution channel, 2019 - 2032 (USD Million)
      • 8.6.6.3. Israel: Human Milk Oligosaccharides (HMO) Market, by Application, 2019 - 2032 (USD Million)
    • 8.6.7. Human Milk Oligosaccharides (HMO) Market - South Africa
      • 8.6.7.1. South Africa: Human Milk Oligosaccharides (HMO) Market, by Type, 2019 - 2032 (USD Million)
      • 8.6.7.2. South Africa.: Human Milk Oligosaccharides (HMO) Market, by Distribution channel, 2019 - 2032 (USD Million)
      • 8.6.7.3. South Africa: Human Milk Oligosaccharides (HMO) Market, by Application, 2019 - 2032 (USD Million)
  • 8.7. Human Milk Oligosaccharides (HMO) Market - Latin America
    • 8.7.1. Latin America: Human Milk Oligosaccharides (HMO) Market, by Type, 2019 - 2032 (USD Million)
    • 8.7.2. Latin America.: Human Milk Oligosaccharides (HMO) Market, by Distribution channel, 2019 - 2032 (USD Million)
    • 8.7.3. Latin America: Human Milk Oligosaccharides (HMO) Market, by Application, 2019 - 2032 (USD Million)
    • 8.7.4. Human Milk Oligosaccharides (HMO) Market - Mexico
      • 8.7.4.1. Mexico: Human Milk Oligosaccharides (HMO) Market, by Type, 2019 - 2032 (USD Million)
      • 8.7.4.2. Mexico.: Human Milk Oligosaccharides (HMO) Market, by Distribution channel, 2019 - 2032 (USD Million)
      • 8.7.4.3. Mexico: Human Milk Oligosaccharides (HMO) Market, by Application, 2019 - 2032 (USD Million)
    • 8.7.5. Human Milk Oligosaccharides (HMO) Market - Brazil
      • 8.7.5.1. Brazil: Human Milk Oligosaccharides (HMO) Market, by Type, 2019 - 2032 (USD Million)
      • 8.7.5.2. Brazil.: Human Milk Oligosaccharides (HMO) Market, by Distribution channel, 2019 - 2032 (USD Million)
      • 8.7.5.3. Brazil: Human Milk Oligosaccharides (HMO) Market, by Application, 2019 - 2032 (USD Million)
    • 8.7.6. Human Milk Oligosaccharides (HMO) Market - Argentina
      • 8.7.6.1. Argentina: Human Milk Oligosaccharides (HMO) Market, by Type, 2019 - 2032 (USD Million)
      • 8.7.6.2. Argentina.: Human Milk Oligosaccharides (HMO) Market, by Distribution channel, 2019 - 2032 (USD Million)
      • 8.7.6.3. Argentina: Human Milk Oligosaccharides (HMO) Market, by Application, 2019 - 2032 (USD Million)

9. Competitive Landscape

  • 9.1. Expansion and Acquisition Analysis
    • 9.1.1. Expansion
    • 9.1.2. Acquisitions
  • 9.2. Partnerships/Collaborations/Agreements/Exhibitions

10. Company Profiles

  • 10.1. Abbott Laboratories
    • 10.1.1. Company Overview
    • 10.1.2. Financial Performance
    • 10.1.3. Product Benchmarking
    • 10.1.4. Recent Development
  • 10.2. BASF S.E
    • 10.2.1. Company Overview
    • 10.2.2. Financial Performance
    • 10.2.3. Product Benchmarking
    • 10.2.4. Recent Development
  • 10.3. Biosynth Carbosynth
    • 10.3.1. Company Overview
    • 10.3.2. Financial Performance
    • 10.3.3. Product Benchmarking
    • 10.3.4. Recent Development
  • 10.4. Chr. Hansen Holding A/S
    • 10.4.1. Company Overview
    • 10.4.2. Financial Performance
    • 10.4.3. Product Benchmarking
    • 10.4.4. Recent Development
  • 10.5. Dextra Laboratories Ltd
    • 10.5.1. Company Overview
    • 10.5.2. Financial Performance
    • 10.5.3. Product Benchmarking
    • 10.5.4. Recent Development
  • 10.6. Dupont Nutrition & Biosciences
    • 10.6.1. Company Overview
    • 10.6.2. Financial Performance
    • 10.6.3. Product Benchmarking
    • 10.6.4. Recent Development
  • 10.7. Elicityl S.A.
    • 10.7.1. Company Overview
    • 10.7.2. Financial Performance
    • 10.7.3. Product Benchmarking
    • 10.7.4. Recent Development
  • 10.8. Glycom A/S
    • 10.8.1. Company Overview
    • 10.8.2. Financial Performance
    • 10.8.3. Product Benchmarking
    • 10.8.4. Recent Development
  • 10.9. Glycosyn
    • 10.9.1. Company Overview
    • 10.9.2. Financial Performance
    • 10.9.3. Product Benchmarking
    • 10.9.4. Recent Development
  • 10.10. Inbiose NV
    • 10.10.1. Company Overview
    • 10.10.2. Financial Performance
    • 10.10.3. Product Benchmarking
    • 10.10.4. Recent Development
  • 10.11. Medolac Laboratories
    • 10.11.1. Company Overview
    • 10.11.2. Financial Performance
    • 10.11.3. Product Benchmarking
    • 10.11.4. Recent Development
  • 10.12. Neolacta Lifesciences Pvt. Ltd
    • 10.12.1. Company Overview
    • 10.12.2. Financial Performance
    • 10.12.3. Product Benchmarking
    • 10.12.4. Recent Development
  • 10.13. Nestle Health Science
    • 10.13.1. Company Overview
    • 10.13.2. Financial Performance
    • 10.13.3. Product Benchmarking
    • 10.13.4. Recent Development
  • 10.14. Royal DSM
    • 10.14.1. Company Overview
    • 10.14.2. Financial Performance
    • 10.14.3. Product Benchmarking
    • 10.14.4. Recent Development
  • 10.15. Royal FrieslandCampina N.V
    • 10.15.1. Company Overview
    • 10.15.2. Financial Performance
    • 10.15.3. Product Benchmarking
    • 10.15.4. Recent Development
  • 10.16. ZuChem
    • 10.16.1. Company Overview
    • 10.16.2. Financial Performance
    • 10.16.3. Product Benchmarking
    • 10.16.4. Recent Development

List of Tables

  • Table 1 Global Human Milk Oligosaccharides (HMO) Market, by Type, 2019 - 2032 (USD Million)
  • Table 2 Global Human Milk Oligosaccharides (HMO) Market, by Application, 2019 - 2032 (USD Million)
  • Table 3 Global Human Milk Oligosaccharides (HMO) Market, by Distribution channel, 2019 - 2032 (USD Million)
  • Table 4 Human Milk Oligosaccharides (HMO) Market Assessment, By Geography, 2019 - 2032 (USD Million)
  • Table 5 North America: Human Milk Oligosaccharides (HMO) Market, by Type, 2019 - 2032 (USD Million)
  • Table 6 North America: Human Milk Oligosaccharides (HMO) Market, by Application, 2019 - 2032 (USD Million)
  • Table 7 North America: Human Milk Oligosaccharides (HMO) Market, by Distribution channel, 2019 - 2032 (USD Million)
  • Table 8 U.S.: Human Milk Oligosaccharides (HMO) Market, by Type, 2019 - 2032 (USD Million)
  • Table 9 U.S.: Human Milk Oligosaccharides (HMO) Market, by Application, 2019 - 2032 (USD Million)
  • Table 10 U.S.: Human Milk Oligosaccharides (HMO) Market, by Distribution channel, 2019 - 2032 (USD Million)
  • Table 11 Canada: Human Milk Oligosaccharides (HMO) Market, by Type, 2019 - 2032 (USD Million)
  • Table 12 Canada: Human Milk Oligosaccharides (HMO) Market, by Application, 2019 - 2032 (USD Million)
  • Table 13 Canada: Human Milk Oligosaccharides (HMO) Market, by Distribution channel, 2019 - 2032 (USD Million)
  • Table 14 Europe: Human Milk Oligosaccharides (HMO) Market, by Type, 2019 - 2032 (USD Million)
  • Table 15 Europe: Human Milk Oligosaccharides (HMO) Market, by Application, 2019 - 2032 (USD Million)
  • Table 16 Europe: Human Milk Oligosaccharides (HMO) Market, by Distribution channel, 2019 - 2032 (USD Million)
  • Table 17 UK: Human Milk Oligosaccharides (HMO) Market, by Type, 2019 - 2032 (USD Million)
  • Table 18 UK: Human Milk Oligosaccharides (HMO) Market, by Application, 2019 - 2032 (USD Million)
  • Table 19 UK: Human Milk Oligosaccharides (HMO) Market, by Distribution channel, 2019 - 2032 (USD Million)
  • Table 20 France: Human Milk Oligosaccharides (HMO) Market, by Type, 2019 - 2032 (USD Million)
  • Table 21 France: Human Milk Oligosaccharides (HMO) Market, by Application, 2019 - 2032 (USD Million)
  • Table 22 France: Human Milk Oligosaccharides (HMO) Market, by Distribution channel, 2019 - 2032 (USD Million)
  • Table 23 Germany: Human Milk Oligosaccharides (HMO) Market, by Type, 2019 - 2032 (USD Million)
  • Table 24 Germany: Human Milk Oligosaccharides (HMO) Market, by Application, 2019 - 2032 (USD Million)
  • Table 25 Germany: Human Milk Oligosaccharides (HMO) Market, by Distribution channel, 2019 - 2032 (USD Million)
  • Table 26 Italy: Human Milk Oligosaccharides (HMO) Market, by Type, 2019 - 2032 (USD Million)
  • Table 27 Italy: Human Milk Oligosaccharides (HMO) Market, by Application, 2019 - 2032 (USD Million)
  • Table 28 Italy: Human Milk Oligosaccharides (HMO) Market, by Distribution channel, 2019 - 2032 (USD Million)
  • Table 29 Spain: Human Milk Oligosaccharides (HMO) Market, by Type, 2019 - 2032 (USD Million)
  • Table 30 Spain: Human Milk Oligosaccharides (HMO) Market, by Application, 2019 - 2032 (USD Million)
  • Table 31 Spain: Human Milk Oligosaccharides (HMO) Market, by Distribution channel, 2019 - 2032 (USD Million)
  • Table 32 Netherlands: Human Milk Oligosaccharides (HMO) Market, by Type, 2019 - 2032 (USD Million)
  • Table 33 Netherlands: Human Milk Oligosaccharides (HMO) Market, by Application, 2019 - 2032 (USD Million)
  • Table 34 Netherlands: Human Milk Oligosaccharides (HMO) Market, by Distribution channel, 2019 - 2032 (USD Million)
  • Table 35 Russia: Human Milk Oligosaccharides (HMO) Market, by Type, 2019 - 2032 (USD Million)
  • Table 36 Russia: Human Milk Oligosaccharides (HMO) Market, by Application, 2019 - 2032 (USD Million)
  • Table 37 Russia: Human Milk Oligosaccharides (HMO) Market, by Distribution channel, 2019 - 2032 (USD Million)
  • Table 38 Asia Pacific: Human Milk Oligosaccharides (HMO) Market, by Type, 2019 - 2032 (USD Million)
  • Table 39 Asia Pacific: Human Milk Oligosaccharides (HMO) Market, by Application, 2019 - 2032 (USD Million)
  • Table 40 Asia Pacific: Human Milk Oligosaccharides (HMO) Market, by Distribution channel, 2019 - 2032 (USD Million)
  • Table 41 China: Human Milk Oligosaccharides (HMO) Market, by Type, 2019 - 2032 (USD Million)
  • Table 42 China: Human Milk Oligosaccharides (HMO) Market, by Application, 2019 - 2032 (USD Million)
  • Table 43 China: Human Milk Oligosaccharides (HMO) Market, by Distribution channel, 2019 - 2032 (USD Million)
  • Table 44 India: Human Milk Oligosaccharides (HMO) Market, by Type, 2019 - 2032 (USD Million)
  • Table 45 India: Human Milk Oligosaccharides (HMO) Market, by Application, 2019 - 2032 (USD Million)
  • Table 46 India: Human Milk Oligosaccharides (HMO) Market, by Distribution channel, 2019 - 2032 (USD Million)
  • Table 47 Malaysia: Human Milk Oligosaccharides (HMO) Market, by Type, 2019 - 2032 (USD Million)
  • Table 48 Malaysia: Human Milk Oligosaccharides (HMO) Market, by Application, 2019 - 2032 (USD Million)
  • Table 49 Malaysia: Human Milk Oligosaccharides (HMO) Market, by Distribution channel, 2019 - 2032 (USD Million)
  • Table 50 Japan: Human Milk Oligosaccharides (HMO) Market, by Type, 2019 - 2032 (USD Million)
  • Table 51 Japan: Human Milk Oligosaccharides (HMO) Market, by Application, 2019 - 2032 (USD Million)
  • Table 52 Japan: Human Milk Oligosaccharides (HMO) Market, by Distribution channel, 2019 - 2032 (USD Million)
  • Table 53 Indonesia: Human Milk Oligosaccharides (HMO) Market, by Type, 2019 - 2032 (USD Million)
  • Table 54 Indonesia: Human Milk Oligosaccharides (HMO) Market, by Application, 2019 - 2032 (USD Million)
  • Table 55 Indonesia: Human Milk Oligosaccharides (HMO) Market, by Distribution channel, 2019 - 2032 (USD Million)
  • Table 56 South Korea: Human Milk Oligosaccharides (HMO) Market, by Type, 2019 - 2032 (USD Million)
  • Table 57 South Korea: Human Milk Oligosaccharides (HMO) Market, by Application, 2019 - 2032 (USD Million)
  • Table 58 South Korea: Human Milk Oligosaccharides (HMO) Market, by Distribution channel, 2019 - 2032 (USD Million)
  • Table 59 Middle East & Africa: Human Milk Oligosaccharides (HMO) Market, by Type, 2019 - 2032 (USD Million)
  • Table 60 Middle East & Africa: Human Milk Oligosaccharides (HMO) Market, by Application, 2019 - 2032 (USD Million)
  • Table 61 Middle East & Africa: Human Milk Oligosaccharides (HMO) Market, by Distribution channel, 2019 - 2032 (USD Million)
  • Table 62 Saudi Arabia: Human Milk Oligosaccharides (HMO) Market, by Type, 2019 - 2032 (USD Million)
  • Table 63 Saudi Arabia: Human Milk Oligosaccharides (HMO) Market, by Application, 2019 - 2032 (USD Million)
  • Table 64 Saudi Arabia: Human Milk Oligosaccharides (HMO) Market, by Distribution channel, 2019 - 2032 (USD Million)
  • Table 65 UAE: Human Milk Oligosaccharides (HMO) Market, by Type, 2019 - 2032 (USD Million)
  • Table 66 UAE: Human Milk Oligosaccharides (HMO) Market, by Application, 2019 - 2032 (USD Million)
  • Table 67 UAE: Human Milk Oligosaccharides (HMO) Market, by Distribution channel, 2019 - 2032 (USD Million)
  • Table 68 Israel: Human Milk Oligosaccharides (HMO) Market, by Type, 2019 - 2032 (USD Million)
  • Table 69 Israel: Human Milk Oligosaccharides (HMO) Market, by Application, 2019 - 2032 (USD Million)
  • Table 70 Israel: Human Milk Oligosaccharides (HMO) Market, by Distribution channel, 2019 - 2032 (USD Million)
  • Table 71 South Africa: Human Milk Oligosaccharides (HMO) Market, by Type, 2019 - 2032 (USD Million)
  • Table 72 South Africa: Human Milk Oligosaccharides (HMO) Market, by Application, 2019 - 2032 (USD Million)
  • Table 73 South Africa: Human Milk Oligosaccharides (HMO) Market, by Distribution channel, 2019 - 2032 (USD Million)
  • Table 74 Latin America: Human Milk Oligosaccharides (HMO) Market, by Type, 2019 - 2032 (USD Million)
  • Table 75 Latin America: Human Milk Oligosaccharides (HMO) Market, by Application, 2019 - 2032 (USD Million)
  • Table 76 Latin America: Human Milk Oligosaccharides (HMO) Market, by Distribution channel, 2019 - 2032 (USD Million)
  • Table 77 Mexico: Human Milk Oligosaccharides (HMO) Market, by Type, 2019 - 2032 (USD Million)
  • Table 78 Mexico: Human Milk Oligosaccharides (HMO) Market, by Application, 2019 - 2032 (USD Million)
  • Table 79 Mexico: Human Milk Oligosaccharides (HMO) Market, by Distribution channel, 2019 - 2032 (USD Million)
  • Table 80 Brazil: Human Milk Oligosaccharides (HMO) Market, by Type, 2019 - 2032 (USD Million)
  • Table 81 Brazil: Human Milk Oligosaccharides (HMO) Market, by Application, 2019 - 2032 (USD Million)
  • Table 82 Brazil: Human Milk Oligosaccharides (HMO) Market, by Distribution channel, 2019 - 2032 (USD Million)
  • Table 83 Argentina: Human Milk Oligosaccharides (HMO) Market, by Type, 2019 - 2032 (USD Million)
  • Table 84 Argentina: Human Milk Oligosaccharides (HMO) Market, by Application, 2019 - 2032 (USD Million)
  • Table 85 Argentina: Human Milk Oligosaccharides (HMO) Market, by Distribution channel, 2019 - 2032 (USD Million)

List of Figures

  • Figure 1. Global Human Milk Oligosaccharides (HMO) Market, 2019 - 2032 (USD Million)
  • Figure 2. Integrated Ecosystem
  • Figure 3. Research Methodology: Top-Down & Bottom-Up Approach
  • Figure 4. Market by Geography
  • Figure 5. Porter's Five Forces
  • Figure 6. Market by Application
  • Figure 7. Global Human Milk Oligosaccharides (HMO) Market, by Application, 2023 & 2032 (USD Million)
  • Figure 8. Market by Type
  • Figure 9. Global Human Milk Oligosaccharides (HMO) Market, by Type, 2023 & 2032 (USD Million)
  • Figure 10. Market by Distribution channel
  • Figure 11. Global Human Milk Oligosaccharides (HMO) Market, by Distribution channel, 2023 & 2032 (USD Million)
  • Figure 12. Human Milk Oligosaccharides (HMO) Market Assessment, By Geography, 2019 - 2032 (USD Million)
  • Figure 13. Strategic Analysis - Human Milk Oligosaccharides (HMO) Market